Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Study highlights undiscovered potential of bacterial compounds and genes linked to colon cancer-related toxin
The last two decades have seen the development of sophisticated computational tools that explore the…
Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested
A drug carrier able to reach the brain, bind to an aggressive type of tumour…
New research highlights the challenges of melanoma diagnosis
QIMR Berghofer researchers have found that nearly a third of melanomas picked up during routine…
Mater patients to help unlock mystery of deadliest breast cancers
- Possible biological explanation for increased cancer risk in dense breasts
- Study finds earlier mammograms for women with family history of breast cancer may not be needed
- ASTRO 2022: Three week hypo-fractionated whole breast irradiation (WBI) with concurrent boost not inferior to conventional WBI with a sequential boost following lumpectomy for high-risk, early-stage breast cancer
Bowel cancer patients at high risk of clinical levels of depression
- CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy
- Pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer
- Applying artificial intelligence in treating Gastro-Intestinal Cancer is now a reality thanks to a grant awarded by the AGITG
Women benefit from mammography screening beyond age 75
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of breast…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.